Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia

Children with immune thrombocytopenia for ≥6 months completing a romiplostim study received weekly subcutaneous romiplostim (1-10 μg/kg targeting platelet counts of 50-200×10(9)/L) in this extension to examine romiplostim’s long-term safety and efficacy. Sixty-five children received romiplostim for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantino, Michael D., Bussel, James B., Blanchette, Victor S., Beam, Donald, Roy, John, Despotovic, Jenny, Raj, Ashok, Carpenter, Nancy, Mehta, Bhakti, Eisen, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821612/
https://www.ncbi.nlm.nih.gov/pubmed/30846500
http://dx.doi.org/10.3324/haematol.2018.202283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821612/
https://www.ncbi.nlm.nih.gov/pubmed/30846500
http://dx.doi.org/10.3324/haematol.2018.202283

Ejemplares similares